Anew Home Hlth Care Location: 7425 Harwood Ave, Wauwatosa, Wisconsin 53213 Ratings:NA Phone: (414) 475-7788 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
St Camillus Home Health Agency Location: 10101 W Wisconsin Ave, Wauwatosa, Wisconsin 53226 Ratings: Phone: (414) 258-2418 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Preferred Home Health Services Location: 811 N Hawley Rd, Suite 102, Wauwatosa, Wisconsin 53213 Ratings:NA Phone: (414) 774-3901 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Maxim Healthcare Services Location: 933 Mayfair Rd Suite 201, Wauwatosa, Wisconsin 53226 Ratings:NA Phone: (414) 475-9330 Health Services: Nursing Care, Home Health Aide |
News Archive
Health reform is on the forefront of everyone's minds. Last month in his weekly address, President Barack Obama touted health insurance "exchanges" which offer Americans a one-stop shopping destination for health coverage.
Military medics hone their medical skills in combat, supporting humanitarian operations and serving in hospitals and clinics across the world. Now, bolstered by a $1.25-million federal grant, the University of South Florida will offer veterans and service members the opportunity to earn a bachelor of science degree in nursing through a program that builds upon their military healthcare training and experience.
An experimental device for removing blood clots in stroke patients dramatically outperformed the standard mechanical treatment, according to research presented by UCLA Stroke Center director Dr. Jeffrey L. Saver at the American Stroke Association's 2012 international conference in New Orleans on Feb. 3.
The National Institutes of Health (NIH) today launched ClinRegs, an online public database of country-specific clinical research regulatory information.
Boehringer Ingelheim presented today for the first time data from a Phase II dose ranging study investigationg the combination of olodaterol, an investigational long-acting beta2-agonist (LABA), and tiotropium, a long-acting muscarinic antagonist (LAMA), in COPD patients, compared to the investigational agent olodaterol alone.
› Verified 8 days ago